Advertisement
Articles
Subscribe to Pharmaceutical Processing Articles

The Lead

Robotics And Medical Marijuana — A Joint Venture

April 21, 2015 | by Meagan Parrish, Editor, Chem.Info | Comments

A startup company that’s found a unique niche in the exploding cannabis industry, Potbotics uses robotic technology to bring medical marijuana use into a new era of high-tech pharma.

TOPICS:

Hiring in biopharma: Rapid industry growth is creating bottlenecks

July 21, 2015 8:32 am | by Eric S. Langer, president and managing partner at BioPlan Associates | Comments

The consistent, rapid growth in the biopharma industry has its downsides that most other industries would envy: chronic inability to hire and retain the right staff.  According to BioPlan Associates’ latest industry study ...

TOPICS:

Could wearables turn traditional trial design on its head?

July 17, 2015 10:15 am | by Thaddeus Wolfram and Jon Lange | Comments

The planning and execution of clinical trials is a complex and deliberate process that must account for multiple factors in order to successfully enable the desired scientific outcome. Tactical coordination of finance, operations, IT and quality are necessary....

TOPICS:

API properties – risk assessment for effective phase I dosage form development decisions

July 9, 2015 4:23 pm | by Anil Kane, Ph.D., Executive Director, Global Head of Formulations, Pharmaceutical Development Services, Patheon | Comments

Characterizing the physicochemical properties of an active pharmaceutical ingredient (API) in a solid state is extremely important in early-stage product development. Understanding these characteristics impacts the choice ...

TOPICS:
Advertisement

Pharmaceutical validation & beyond: Creating a trusted supply chain

July 9, 2015 4:05 pm | by Jim Lee, Vice President of Product Management, Systech | Comments

The ability to track raw material sources before they hit the manufacturing line adds a critical layer of supply chain security. After all, no one wants saw dust turning up in baby powder. What is the difference between validation and qualification?

TOPICS:

The U.S. drug shortage -- by the numbers

July 9, 2015 3:55 pm | Comments

The U.S. has a drug shortage problem that refuses to go away. Though the FDA has gotten better at stopping new shortages in recent years, the total number of drugs in short supply remains stubbornly high.

TOPICS:

Pharma playing key role in economic, chemical growth

July 9, 2015 3:48 pm | by Editors | Comments

As its name would suggest, the American Chemistry Council (ACCs) works with and represents the interests of companies engaged in the global, $812 billion business of chemistry. Many of the businesses housed in the chemical fraternity ...

TOPICS:

Meeting formulation and delivery challenges for macromolecular drugs

July 9, 2015 3:47 pm | by Julien Meissonnier, Catalent Pharma Solutions | Comments

The Biotech market reached revenues of $172 billion in 2014, which accounts for 23 percent of global pharmaceutical drug revenues, and it is expected to grow to 27 percent by 2020. In a recent drug delivery landscape ...

TOPICS:

Setting the stage

July 9, 2015 3:26 pm | by Jeff Reinke, Editorial Director | Comments

A closer look at how Grand Rapids Aseptic Manufacturing, headquartered in Grand Rapids, MI, has implemented a redefined focus and smart investment strategies to elevate performance levels and capabilities.

TOPICS:
Advertisement

Meet the ‘Breaking Bad’ chemist who’s helping make science cool

June 16, 2015 10:48 am | by Meagan Parrish, Editor, Chem.Info | Comments

Dr. Donna Nelson, the former scientific advisor to the hit-show “Breaking Bad” and president-elect of the American Chemical Society talks Hollywood, making meth, and the most urgent issue facing the chemical industry.

TOPICS:

Improved detection of pyrogens using the monocyte activation test

June 10, 2015 12:23 pm | by Audrey Borel, PharmD Global Product Manager - Rapid Release Testing Pharma, EMD Millipore; Bodo Holtkamp, Biotest AG, GBU Mikrobiologie; Gabriele Schmitz, Biotest AG, GBU Mikrobiologie; Thomas Hartung, Johns Hopkins University, Center for Alternatives | Comments

When present in pharmaceutical products, pyrogenic substances can prove harmful to humans by causing life threatening fevers. Therefore, testing of pharmaceutical products for pyrogens is critical to ensure patient safety.

TOPICS:

Could Maple Syrup Help Cut Use of Antibiotics?

April 17, 2015 3:41 pm | by McGill University | Comments

Syrup extract found to make antibiotics more effective against bacteria.

TOPICS:

Why Calibration Needs to Be Made Part of Your APM Strategy

April 8, 2015 11:12 am | by Dan Miklovic, Principal Analyst at LNS Research | Comments

Just as calibration needs to be part of your quality processes, it absolutely needs to be part of your asset performance management (APM) strategy as well.

TOPICS:

How Drug Manufacturers Are Impacting The Death Penalty Debate

March 24, 2015 11:22 am | by Meagan Parrish, Editor, Chem.Info | Comments

Polls generally show that the majority of Americans are on board with the death penalty. In October 2014, Gallup reported that 63 percent of Americans were in favor of capital punishment while 33 percent were opposed.

TOPICS:

Packaging Entrepreneurs: Legacy Pharmaceutical Packaging

February 20, 2015 10:17 am | by Mike Auerbach, Editor-In-Chief | Comments

Legacy Pharmaceutical Packaging, in St. Louis, Missouri is proud of its entrepreneurial spirit, its operational flexibility and technological expertise, and the breadth of packaging services it offers to its customers in a wide variety of segments of the healthcare industry.

TOPICS:

Surviving Pharma’s Uncertain Future

November 20, 2014 10:08 am | by Nathan Furr and Jeff Dyer | Comments

The average cost of developing an approved therapy is around $4.3 billion dollars for companies with three or more approved therapies, according to an analysis completed by Forbes. Imagine, then, our surprise when we discovered a biotechnology company outside of New York City that had developed three approved therapies for an average cost of $0.7 billion dollars – less than 20 percent of the industry average.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading